000			01998 a2200529 4500
005			20250515040214.0
264		0	_c20061101
008			200611s 0 0 eng d
022			_a0953-816X
024	7		_a10.1111/j.1460-9568.2006.04954.x _2doi
040			_aNLM _beng _cNLM
100	1		_aSt-Hilaire, Michel
245	0	0	_aImpaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice. _h[electronic resource]
260			_bThe European journal of neuroscience _cAug 2006
300			_a795-805 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdaptation, Physiological _xdrug effects
650	0	4	_aAnimals
650	0	4	_aAntiparkinson Agents _xpharmacology
650	0	4	_aBenserazide _xpharmacology
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aDNA-Binding Proteins _xgenetics
650	0	4	_aDenervation
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine _xdeficiency
650	0	4	_aDopamine Agents
650	0	4	_aDrug Resistance _xgenetics
650	0	4	_aEnkephalins _xgenetics
650	0	4	_aLevodopa _xpharmacology
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Knockout
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aNeural Pathways _xinjuries
650	0	4	_aNeurotensin _xgenetics
650	0	4	_aNuclear Receptor Subfamily 4, Group A, Member 1
650	0	4	_aParkinson Disease _xdrug therapy
650	0	4	_aReceptors, Cytoplasmic and Nuclear _xgenetics
650	0	4	_aReceptors, Dopamine D3 _xdrug effects
650	0	4	_aReceptors, Steroid _xgenetics
650	0	4	_aTranscription Factors _xgenetics
700	1		_aBourhis, Emmanuelle
700	1		_aLévesque, Daniel
700	1		_aRouillard, Claude
773	0		_tThe European journal of neuroscience _gvol. 24 _gno. 3 _gp. 795-805
856	4	0	_uhttps://doi.org/10.1111/j.1460-9568.2006.04954.x _zAvailable from publisher's website
999			_c16516434 _d16516434